Yanhu Xie

Dr. Yanhu Xie


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2022 in Pain and Therapy
Verified
Journal Article
Open access
PDF file
RXRuyi Xing
Ruyi Xing
YYYang Yang
Yang Yang
MZMin Zhang
Min Zhang
HWHanyu Wang
Hanyu Wang
MTMengyuan Tan
Mengyuan Tan
YXYanhu Xie
Yanhu Xie
Introduction This study assessed the influence of transcutaneous electrical acupoint stimulation (TEAS) combined with transversus abdominis plane block (TAPB) on the recovery of elderly patients undergoing laparoscopic gastric cancer surgery. Methods Ninety patients (age ≥ 60 years) undergoing laparoscopic gastric cancer surgery were randomly divided into general anesthesia group (group G), TAPB group (group NG), and TEAS combined with TAPB group (group NTG). Patients in the NTG group received TEAS at PC6, LI4, and ST36 acupoints and TAPB. Patients in the NG group received TAPB. The quality of recovery (QoR) was assessed using the QoR-15 questionnaire. The percentages of T lymphocyte subsets were determined. Consumption of anesthetics, extubation time, visual analog scale (VAS) scores, time of first postoperative ambulation and flatus, and postoperative adverse events were also recorded. Results QoR-15 scores on postoperative day (POD) 3 and POD 7 were higher in the NTG group than in the G and NG groups (P < 0.05). On POD 1 and POD 3, the percentages of CD3+ and CD4+ T cells and the CD4+/CD8+ ratio were higher and the percentage of CD8+ T cells was lower in the NTG group than in the G and NG groups (P < 0.05). Remifentanil consumption, and the incidence of postoperative nausea and vomiting (PONV) were lower and extubation time and time of first postoperative flatus were shorter in the NTG group than in the G and NG groups (P < 0.05). Compared with the G group, the VAS scores on POD 1 were lower in the NG group and those on POD 2 were lower in the NTG group (P < 0.05). Conclusion The combination of TEAS and TAPB ameliorated postoperative pain, improved immune and gastrointestinal function, reduced the incidence of PONV, and effectively promoted postoperative recovery in elderly patients undergoing laparoscopic gastric cancer surgery. Trial Registration Chinese Clinical Trial Registry (ChiCTR2100042119).

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
WZWanjun Zhou
Wanjun Zhou
JWJiawu Wang
Jiawu Wang
CHChengyun Hu
Chengyun Hu
FDFeibiao Dai
Feibiao Dai
ZZZhetao Zhang
Zhetao Zhang
YXYanhu Xie
Yanhu Xie
Background. Comparing the effect of two different κ‐receptor agonists, nalbuphine and oxycodone, and regular morphine in patients for prophylactic analgesia of acute pain after daytime laparoscopic cholecystectomy. Methods. One hundred and twenty‐four patients undergoing laparoscopic cholecystectomy were randomly allocated to receive nalbuphine (group N), oxycodone (group O), and morphine (group M). The three groups were all given intravenous injection (iv.) of 0.15 mg/kg injection before incision and 0.05 mg/kg injection at the end of pneumoperitoneum. The Visual Analogue Scale (VAS) scores (incision, visceral, and shoulder) and Ramsay sedation scores at 1, 2, 4, 8, 12, 16, 20, and 24 hours after surgery, the time of extubation, the incidence of postoperative adverse events, the satisfaction of pain treatment, and the duration of stay after surgery were all recorded. Results. Compared with group M, the VAS scores of visceral pain at rest decreased in group N and group O at 1‐8 h after surgery (P < 0.05). The VAS scores of visceral pain at movement in group N decreased longer than those in group O (P < 0.05). Compared with that of group M, the postoperative time in Ramsay sedation score of group O increased longer than that of group N (P < 0.05). Compared with group N, patients had worse sleep quality in group O, longer length of stay in group M, and lower satisfaction in both groups. Conclusion. Compared with morphine, prophylactic use of the κ‐receptor agonists, nalbuphine and oxycodone, during laparoscopic cholecystectomy can reduce postoperative visceral pain. Furthermore, the nalbuphine group had fewer adverse reactions, better analgesia, and better satisfaction.

1 December 2024 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
HZHuaming Zhang
Huaming Zhang
MZMin Zhang
Min Zhang
LHLina Hao
Lina Hao
QLQianqian Li
Qianqian Li
QLQijian Li
Qijian Li
YXYanhu Xie
Yanhu Xie
Purpose: To evaluate and compare the effects of ciprofol and propofol on postoperative nausea and vomiting (PONV) in patients undergoing outpatient hysteroscopy. Design: Double-blind randomized controlled trial. Methods: This study included 1104 patients scheduled for elective outpatient hysteroscopy. Patients were randomly grouped to ciprofol Group (Group C, n = 539) and propofol Group (Group P, n = 547). Anesthesia was induced by sufentanil 0.1 ug/kg combined with ciprofol 0.3mg/kg or propofol 2.5mg/kg. Anesthesia was maintained by ciprofol 1 to 1.5mg/kg/h or propofol 3 to 5mg/kg/h. The primary outcome of the study was PONV after surgery 1h and 24h. Secondary outcomes included heart rate (HR), mean arterial blood pressure (MAP), SpO2 before anesthesia (T1), 3 min after anesthesia (T2) and at the end of surgery (T3); the time of consciousness loss, recovery, hysteroscopy and discharge; and the incidence of adverse drug reactions such as hypotension, respiratory depression, bradycardia and injection pain was recorded in the two groups. Results: Compared with group P, MAP and SpO2 at T2 were significantly increased in group C (P< 0.05). Although there was no significant difference in the incidence of PONV at 1h and 24h after surgery between 2 groups (P > 0.05), the incidence of hypotension, injection pain and respiratory depression in group C were significantly reduced, compared with group P. (P< 0.05). Conclusion: Compared with propofol, ciprofol has a similar incidence of PONV and lower adverse effects such as hypotension, injection pain and respiratory depression in outpatient hysteroscopy.

9 March 2024 in Perioperative Medicine
Verified
Journal Article
Open access
PDF file
JFJun Fang
Jun Fang
JYJia Yang
Jia Yang
MZMingyu Zhai
Mingyu Zhai
QZQiong Zhang
Qiong Zhang
MZMin Zhang
Min Zhang
YXYanhu Xie
Yanhu Xie
Study objectives: To assess whether preoperative dexmedetomidine (DEX) nasal drips combined with conventional treatment could mitigate the occurrence of postoperative delirium (POD). Design: A prospective randomised controlled study. Setting: The cardiac surgery intensive care unit (CSICU) and patient hospitalisation ward at a university hospital. Participants: A total of 100 patients (aged ≥60 years) undergoing cardiac surgery at a university hospital between 7 January 2022, and 30 November 2022 met the eligibility criteria and were included in the study. Interventions: Patients with sleep disorders (Pittsburgh Sleep Quality Index ≥8) were divided into two groups: Group A (the placebo group, n=50), receiving a short-term preoperative placebo combined with conventional treatment and Group B (the DEX group, n=50), receiving short-term preoperative DEX combined with conventional treatment. Measurements and results: The Confusion Assessment Method for the ICU (CAM-ICU) was used for POD assessment in the CSICU, while the CAM was employed to assess delirium in the patient ward. Group B demonstrated a reduced incidence of POD compared to Group A (12% vs. 30%, odds ratio: 0.318, 95% confidence interval: 0.112–0.905, p=0.027). Conclusion: The combined treatment involving DEX demonstrated a decreased incidence of POD in elderly individuals with sleep disorders undergoing cardiac surgery compared to the placebo combination treatment. Trial registration: URL: www.chictr.org.cn with registration number ChiCTR 2100043968, registered on 06/03/2021.

20 November 2023 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
JFJun Fang
Jun Fang
JYJia Yang
Jia Yang
MZMingyu Zhai
Mingyu Zhai
QZQiong Zhang
Qiong Zhang
MZMin Zhang
Min Zhang
YXYanhu Xie
Yanhu Xie
Background: This study aimed to investigate the effects of perioperative dexmedetomidine (DEX) infusion rates on the postoperative short-term cognitive function. Methods: A total of 88 patients aged ≥ 60 years who underwent cardiac surgery from January 2022 to November 2022 at the First Affiliated Hospital of The University of Science and Technology of China (USTC) were included. Based on a single-center pilot analysis, patients were divided into two groups according to the rate of intraoperative DEX infusion, which started after tracheal intubation and continued until 1 h before extubation in the cardiac surgery intensive care unit. In Group L (n = 44), the infusion rate was 0.1–0.5 µg/kg/h (low-dose group), whereas in Group H (n = 44), the infusion rate was 0.5–0.9 µg/kg/h (high-dose group). Clinical outcomes were then compared between the groups. The Mini–Mental State Evaluation (abbreviated as MMSE1, MMSE2, MMSE3, and MMSE4) scale was used for the assessment of cognitive function, which was conducted on postoperative Days 2 (T1), 7 (T2), 14 (T3), and 28 (T4), with the score from postoperative Day 2 (MMSE1) considered as the primary observation. Results: Patients in Group L had higher MMSE1 scores compared to those in Group H (26.0 [24.0, 27.0] vs. 24.5 [22.0, 26.0], p = 0.046), and there was no significant difference in the scores between the groups at all subsequent time points. Group H exhibited a higher incidence of hypotension and bradycardia compared to Group L (p = 0.044 and p = 0.047, respectively). Conclusions: Compared to a high dose (0.5–0.9 µg/kg/h) of DEX infusion, a low-dose (0.1–0.5 µg/kg/h) infusion started after induction of anesthesia and continued until 1 h before extubation improved postoperative cognitive function scores on postoperative Day 2 in patients aged 60 years and older. Trial registration: URL: www.chictr.org.cn with registration number ChiCTR2100055093, registered on 31/12/2021.

1 March 2025 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
YZYingting Zhou
Yingting Zhou
ZLZiYou Liu
ZiYou Liu
QLQianQian Li
QianQian Li
PNPengFei Ni
PengFei Ni
ZLZuoHui Li
ZuoHui Li
YXYanhu Xie
Yanhu Xie
Objective: To evaluate the effects of different ciprofol doses on hemodynamics in patients undergoing cardiac surgery. Methods: 209 patients were randomly divided into four groups: 0.2 mg/kg etomidate group (group E, n = 50), 0.2 mg/kg, 0.3mg/kg, 0.4mg/kg ciprofol group (group A, n = 53, group B, n = 51, group C, n = 54). Mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), stroke volume (SV), systemic vascular resistance (SVR), and bispectral index were recorded at the following time points: 5 minutes after entering the operating room (T0); before anesthesia induction (T1); immediately after induction (T2); 1 minute and 2 minutes after induction (T3~T4); at intubation (T5); 1 minute, 3 minutes, 5 minutes and 10 minutes after intubation (T6~T9); at skin incision (T10). The incidence of hypotension and bradycardia and the doses of vasoactive drugs were recorded. Results: Compared with T0, HR, MAP, SV, CO all decreased to varying degrees after administration, and the decrease time in Group B and Group C were earlier than that in other two groups (P < 0.05). SVR increased slowly after T4 in all groups, but there was no significant differences (P > 0.05). Compared with group E, the norepinephrine dose was significantly lower in groups A and B (both P < 0.05). Group C showed a greater decline in CO and SV than the other three groups from T7 to T10 (P < 0.05), while there was no significant difference between groups A and E in CO and groups A, B, and E in SV (P > 0.05). No significant differences were observed in MAP, SVR, and the incidences of hypotension and bradycardia among the four groups (P > 0.05). Conclusion: 0.2 mg/kg ciprofol has the least impact on hemodynamics in patients undergoing cardiac surgery, and reduced norepinephrine use.